IP Verse

H Lundbeck competitive analysis

Latest publications and patents of H Lundbeck New

Explore the latest publications and patents granted to H Lundbeck, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of H Lundbeck

EP2608789
Aug 21, 2024Therapeutic Uses Of 1-[2-(2,4-Dimethyl-Phenylsulfanyl)Phenyl]PiperazinePatent Maintained As Amended
EP3345604
Jun 7, 2023Nalmefene For Reduction Of Alcohol Consumption In Specific Target PopulationsGranted And Under Opposition
EP3615518
Dec 15, 2021Process For The Manufacture Of Vortioxetine Hbr Alpha-FormGranted And Under Opposition
EP3138564
Jan 31, 2018Nalmefene For Reduction Of Alcohol Consumption In Specific Target PopulationsRevoked
EP2906546
Jan 10, 2018BenzamidesNo Opposition Filed Within Time Limit

Latest patents of H Lundbeck opposed by its competitors

Explore H Lundbeck's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2608789
Aug 21, 2024Therapeutic Uses Of 1-[2-(2,4-Dimethyl-Phenylsulfanyl)Phenyl]Piperazine1
EP3345604
Jun 7, 2023Nalmefene For Reduction Of Alcohol Consumption In Specific Target Populations2
EP3615518
Dec 15, 2021Process For The Manufacture Of Vortioxetine Hbr Alpha-Form1
EP3138564
Jan 31, 2018Nalmefene For Reduction Of Alcohol Consumption In Specific Target Populations1

Latest PTAB cases involving H Lundbeck

Discover the latest PTAB cases involving H Lundbeck, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing H Lundbeck with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
H LUNDBECK - 5 - - Non-Active
ALFRED E TIEFENBACHER443 - - Highly Aggressive
BIOGARAN12 - - - Highly Aggressive
GENERICS UK212 - - - Highly Aggressive